Literature DB >> 19375588

Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis.

Jonathan E Campbell1, Sergiu Fediuc, Thomas J Hawke, Michael C Riddell.   

Abstract

Glucocorticoids (GCs) have long been thought to be lipolytic in nature. Recently, however, increased exposure to GCs in insulin-sensitive tissues has been associated with lipid accumulation and metabolic complications, regardless of plasma concentrations. Intracellular GC action is determined by both 11-beta hydroxysteroid dehydrogenase type 1 (11betaHSD1) and the GC receptor (GR). We hypothesized that exercise training would increase 11betaHSD1 and GR protein in adipose tissue, resulting in increased lipolysis. To test the effects of exercise on adipose tissue GR and 11betaHSD1 protein, 2 sets of hamsters were trained for 6 weeks: young, diet-induced obese animals and older, overweight animals. Young (6 week old) hamsters, fructose-fed to induce an obese phenotype, and older (6 month old) hamsters were randomly divided into exercising and sedentary groups. Exercise training decreased adipose tissue mass in both fructose-fed and older hamsters. In addition, exercise training increased 11betaHSD1 (31.5% +/- 15% and 20.0% +/- 7%, fructose-fed and older, respectively) and GR (45.6% +/- 14% and 61.1% +/- 27%, fructose-fed and older, respectively) protein expression in the perirenal adipose depot and increased 11betaHSD1 (16.7% +/- 7%, P = .09) and GR (47.4% +/- 19%, P < .05) in the subcutaneous adipose depot of the older hamsters. To determine the metabolic effect of increased GC exposure in adipocytes, 3T3-L1 adipocytes were treated with corticosterone for 24 hours; and measures of lipolytic rates were conducted. Low concentrations of GCs (0.01-0.1 micromol/L) increased GR (44.1% +/- 18%, P < .05) and 11betaHSD1 (95.3% +/- 24%) protein expression, as well as lipolytic rates (34.6% +/- 6%) as measured by glycerol release. The increased lipolysis was blocked by RU486, a GR antagonist, suggesting that the elevated lipolysis was a direct result of GC action. These results suggest that exercise training amplifies the activity of GCs in adipose tissue of overweight animals through alterations in 11betaHSD1 and GR despite differences in age and amounts of adiposity. In vitro, GCs are capable of increasing lipolysis, but depend upon the presence of GR. We propose that GCs play a significant role in changing the phenotype of adipose tissue during exercise training, resulting in decreased fat mass.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375588     DOI: 10.1016/j.metabol.2009.01.002

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  10 in total

1.  Effects of high-intensity interval training on adipose tissue lipolysis, inflammation, and metabolomics in aged rats.

Authors:  Lei Sun; Fang-Hui Li; Tao Li; Zhu Min; Luo-Dan Yang; Hao-En Gao; Da-Shuai Wu; Tian Xie
Journal:  Pflugers Arch       Date:  2020-01-31       Impact factor: 3.657

2.  Curcumin limits weight gain, adipose tissue growth, and glucose intolerance following the cessation of exercise and caloric restriction in rats.

Authors:  Trevor Teich; Jacklyn A Pivovarov; Deanna P Porras; Emily C Dunford; Michael C Riddell
Journal:  J Appl Physiol (1985)       Date:  2017-08-24

Review 3.  The glucocorticoid receptor: cause of or cure for obesity?

Authors:  Kezia John; Joseph S Marino; Edwin R Sanchez; Terry D Hinds
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-29       Impact factor: 4.310

4.  Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.

Authors:  Ying Wang; Limei Liu; Hanze Du; Yoshiko Nagaoka; Winnie Fan; Kabirullah Lutfy; Theodore C Friedman; Meisheng Jiang; Yanjun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-31       Impact factor: 4.310

5.  Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ).

Authors:  Terry D Hinds; Lance A Stechschulte; Harrison A Cash; Donald Whisler; Ananya Banerjee; Weidong Yong; Saja S Khuder; Meenakshi K Kaw; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  J Biol Chem       Date:  2011-10-12       Impact factor: 5.157

6.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

7.  FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγ.

Authors:  Lance A Stechschulte; Terry D Hinds; Saja S Khuder; Weinian Shou; Sonia M Najjar; Edwin R Sanchez
Journal:  Mol Endocrinol       Date:  2014-06-16

8.  Glucocorticoid antagonism limits adiposity rebound and glucose intolerance in young male rats following the cessation of daily exercise and caloric restriction.

Authors:  Trevor Teich; Emily C Dunford; Deanna P Porras; Jacklyn A Pivovarov; Jacqueline L Beaudry; Hazel Hunt; Joseph K Belanoff; Michael C Riddell
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-05-03       Impact factor: 4.310

Review 9.  The Molecular Mechanism Underlying Continuous Exercise Training-Induced Adaptive Changes of Lipolysis in White Adipose Cells.

Authors:  Junetsu Ogasawara; Tetsuya Izawa; Tomonobu Sakurai; Takuya Sakurai; Ken Shirato; Yoshinaga Ishibashi; Hitoshi Ishida; Hideki Ohno; Takako Kizaki
Journal:  J Obes       Date:  2015-05-13

10.  PTPIP51: a new interaction partner of the insulin receptor and PKA in adipose tissue.

Authors:  M A Bobrich; S A Schwabe; A Brobeil; M Viard; M Kamm; F C Mooren; K Krüger; C Tag; M Wimmer
Journal:  J Obes       Date:  2013-03-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.